- PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS
-
Compounds of Formula (I) and pharmaceutically acceptable salts thereof in which X1, X2, X3, L, R3, R4, R5, R7 and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.
- -
-
Paragraph 00426
(2013/05/22)
-
- PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS
-
Compounds of Formula (I) and pharmaceutically acceptable salts thereof in which X1, X2, L, R3, R4, R5, R7 and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.
- -
-
Page/Page column 54
(2012/04/04)
-
- PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS
-
Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which X1, X2, L, R3, R4, R5, R6, R6a, R7, R9, R9a, and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.
- -
-
Page/Page column 85
(2011/12/04)
-
- Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
-
The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula Ia-If: or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
- -
-
Page/Page column 47
(2010/02/11)
-